Egg yolk IgE (kU/L) Change (V5 V0) -0.090 (-0.20 0.28) -0.500 (-0.91 0.76) 0.90 – – – Median (Min-Max) OVO IgE (kU/L) Change (V5 V0) -0.520 (-1.99 0.00) -0.640 (-3.87 0.80) 0.57 – – – Median (Min-Max) OVA IgE (kU/L) Change (V5 V0) -0.180 (-1.35 0.36) -0.930 (-6.30 -0.15) 0.20 – – – Median (Min-Max) a Change (V5 V0) of Test product Change (V5 V0) of Placebo – – – Change over time of CD63+ and CD203c+ cells in placebo (left panels) and HydE Figure 3. (right panels) groups. (Dotted lines are patients who passed the OFC, while patients with the full line did not pass the OFC).
Egg yolk IgE (kU/L) Median (Min-Max) Change (V5 – V0) -0.090 (-0.20 – 0.28) -0.500 (-0.91 – 0.76) 0.90 OVO IgE (kU/L) Median (Min-Max) Change (V5 – V0) -0.520 (-1.99 – 0.00) -0.640 (-3.87 – 0.80) 0.57 OVA IgE (kU/L) Median (Min-Max) Change (V5 – V0) -0.180 (-1.35 – 0.36) -0.930 (-6.30 – -0.15) 0.20 a Change (V5 – V0) of Test product – Change (V5 – V0) of Placebo Figure 3. Change over time of CD63+ and CD203c+ cells in placebo (left panels) and HydE (right panels) groups. (Dotted lines are patients who passed the OFC, while patients with the full line did not pass the OFC).
Egg_AAM.docx